Technical Analysis for RGEN - Repligen Corporation

Grade Last Price % Change Price Change
grade C 143.35 0.95% 1.35
RGEN closed down 3.93 percent on Tuesday, August 11, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical RGEN trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.95%
MACD Bearish Signal Line Cross Bearish 0.95%
1,2,3 Pullback Bullish Bullish Swing Setup 0.95%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.95%
Down 3 Days in a Row Weakness 0.95%
Down 4 Days in a Row Weakness 0.95%
Down 5 Days in a Row Weakness 0.95%
1,2,3 Pullback Bullish Bullish Swing Setup -3.02%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.02%
Multiple of Ten Bearish Other -3.02%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Repligen Corporation, a life sciences company, engages in the development, production, and commercialization of consumable products used in the process of manufacturing biological drugs. Its bioprocessing products are sold to various life sciences and biopharmaceutical companies worldwide. The company manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. It also supplies various growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, the company develops and markets its OPUS brand series of pre-packed ‘plug-and-play' chromatography columns, and provides ELISA test kits to ensure final product quality. Further, Repligen has a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and a orphan drug candidate in Phase 1 development. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Natural Sciences Consumable Products Monoclonal Antibody Bioprocessing

Is RGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 159.97
52 Week Low 72.32
Average Volume 690,939
200-Day Moving Average 106.87
50-Day Moving Average 129.52
20-Day Moving Average 142.94
10-Day Moving Average 150.89
Average True Range 5.52
ADX 34.37
+DI 29.62
-DI 24.56
Chandelier Exit (Long, 3 ATRs ) 143.41
Chandelier Exit (Short, 3 ATRs ) 136.69
Upper Bollinger Band 161.22
Lower Bollinger Band 124.66
Percent B (%b) 0.47
BandWidth 25.57
MACD Line 6.33
MACD Signal Line 6.74
MACD Histogram -0.4132
Fundamentals Value
Market Cap 5.29 Billion
Num Shares 37.3 Million
EPS 0.51
Price-to-Earnings (P/E) Ratio 278.43
Price-to-Sales 12.40
Price-to-Book 6.72
PEG Ratio 2.55
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 151.97
Resistance 3 (R3) 152.75 150.20 150.31
Resistance 2 (R2) 150.20 147.66 149.81 149.76
Resistance 1 (R1) 146.10 146.09 144.83 145.32 149.20
Pivot Point 143.55 143.55 142.91 143.16 143.55
Support 1 (S1) 139.45 141.01 138.18 138.68 134.80
Support 2 (S2) 136.90 139.44 136.51 134.24
Support 3 (S3) 132.80 136.90 133.69
Support 4 (S4) 132.03